Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | APC |
Variant | S31fs |
Impact List | frameshift |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | APC S31fs results in a change in the amino acid sequence of the Apc protein beginning at aa 31 of 2843, likely resulting in premature truncation of the functional protein (UniProt.org). S31fs has not been characterized, however, due to the effects of other truncation mutations downstream of S31 (PMID: 18199528, PMID: 10346819), is predicted to lead to a loss of Apc protein function. |
Associated Drug Resistance | |
Category Variants Paths |
APC mutant APC inact mut APC S31fs |
Transcript | NM_000038.6 |
gDNA | chr5:g.(112754980_112754981) |
cDNA | c.(91_90) |
Protein | p.S31fs |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001127510 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407448.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354895.2 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_000038 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_000038.5 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001127510.2 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407452.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354896.2 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407460.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354903.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407449.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354899.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407458.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407447.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354896.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407454.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_000038.6 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001127510.3 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407469.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407450.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407456.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354903.2 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407467.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407457.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407455.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001407459.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354895.1 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
NM_001354899.2 | chr5:g.(112754980_112754981) | c.(91_90) | p.S31fs | RefSeq | GRCh38/hg38 |
Molecular Profile | Protein Effect | Treatment Approaches |
---|---|---|
APC S31fs | loss of function - predicted | CTNNB1 Inhibitor Tankyrase Inhibitor |